Fundación Pública Andaluza Progreso y Salud
Contact information
Fundación Pública Andaluza Progreso y Salud
Javier Montero Plata, Director de la Oficina de Transferencia de Tecnología del Sistema Sanitario Público de Andalucía
C/ Isaac Newton 4, 3ª Planta, Noroeste - Pabellón de Italia
Sevilla
Sevilla
955040450
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Biodrugs
- Biomarkers
- Stem cells
- Biological defense
- In vitro diagnostics
- Medical devices
- Drug delivery
- Blood products
- Screening
- Cellular Therapy
- Gene Therapy
- Biomaterials and tissue therapy
- Transplant
- Vaccines
- Therapeutic areas
- Analgesia & Pain
- Dermatology
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Immunology
- Odontology
- Ophtalmology and optometry
- Oncology
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- B. Agrifood Biotechnology
- Food
- Functional Food
- C. Industrial Biotechnology
- Cell lines
- D. Services
- R&D services
- Bioinformatics
- Biotechnolgy kits
- Pharmacogenomics
- Genomics
- Scientific and technical instruments
- Internet and information technologies
- Metabolomics
- Nanotechnology and in silico biology
- Proteomics
- Professional services
- Training and spreading
- Human Resources
Commissions
The Andalusian Public Foundation Progress and Health (FPS) is an organization that belongs to the Andalusian Regional Ministry of Health and Social Wellness. It is the central entity which provides services to the Andalusian Public Health System (SSPA) through three areas of activity: support and manage of research, ICT development, and training and professional competence evaluation.
Products and services
FPS is in duty of technology transfer of the SSPA that is managed by Technology Transfer Office (OTT-SSPA) that is organized as a network structure that collaborates with the Network of Research Management Foundations (RFGI) which operates at a local level.
The OTT-SSPA offers specific services to:
- SSPA research community:
- R&D results protection
- intellectual property rights management
- technology transfer
- establishment of business alliances
- spin-offs creation
- Healthcare, pharmaceutical and biotechnology industries:
- research groups identification
- technology offers
- reverse technology transfer
- public-private financing
- business attraction
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| GENYO-20001 CRISPNA, A NEW TOOL FOR GENOME EDITING AND DIAGNOSIS | Gene Therapy, Cell Therapy | R&D | |
| FISEVI-13002 CANNABIOTICS | Biodrugs/ Drugs | Oncología | Preclinical |
| FIBICO-14003 LISED OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MUSCULAR SKELETAL INJURIES | Gene Therapy, Cell Therapy | Desórdenes musculoesqueléticos | R&D |
| CABIMER-19002 NON-VIRAL VECTORS FROM MESOPOROUS NANOPARTICLES FOR THEIR APPLICATION IN GENE THERAPY FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | Gene Therapy, Cell Therapy | Oftalmología y optometría | R&D |
| CABIMER- 21001 Use of melatonin to improve the therapeutic potential of mesenchymal stem cells in cancer | Biodrugs/ Drugs | Oncología | R&D |
| Product / Service | Type | Development phase |
|---|---|---|
| Screening Cell lines & Animal Models | Screening/Drug Discovery | R&D |
| Hybridome/Antibody Production Platform | Enabling Technologies | R&D |
| Liposome delivery System (Prostate Cancer) | Drug Delivery | R&D |
| Maturing technological platform in advanced therapies | CRO, CMO | Clinical Validation |